GENEWIZ and the BIRD Foundation to Present a Case Study on International Funding Collaboration at BioNJ

Oct 21, 2015, 19:41 ET from GENEWIZ

SOUTH PLAINFIELD, N.J., Oct. 21, 2015 /PRNewswire/ -- Leading global genomics service provider, GENEWIZ, along with the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD Foundation), will present a case study on international funding opportunities and how they promote collaborations to advance scientific research during the BioNJ's Entrepreneurship Program. The workshop takes place 8 a.m. to 1 p.m., October 29, at the Livingston Campus of Rutgers University.

Logo - http://photos.prnewswire.com/prnh/20151021/279454LOGO

Earlier this year, GENEWIZ, a genomics service provider of Sanger sequencing, gene synthesis, high-throughput sequencing and GLP-CLIA regulatory services, announced a partnership with Hy Laboratories Ltd. (hylabs), Israel's premier provider of microbiology and molecular and cell biology products and services. The joint venture is focusing on the development of novel diagnostic panels for the determination of the gut microbiome in obesity and diabetes. It was one of eleven new projects granted funding this year from the BIRD Foundation.

"The partnership between GENEWIZ and hylabs, pairs up hylabs' patient network and GENEWIZ's genomics development pipeline, to help improve stratification for bariatric surgical intervention and alternative treatment options for patients suffering with diabetes and obesity," said Steve Manobianco, Vice President, Global Sales & Marketing, GENEWIZ, who will speak at the event. "The partnership would not have been possible without the grant from the BIRD Foundation through their mission to stimulate R&D for the mutual benefit of both the United States and Israel."

Awarded bi-annually, the BIRD Foundation approves grants to promote industrial research and development collaborations between United States- and Israeli-based companies for joint product development spanning various technological fields, such as healthcare. BIRD funded projects have helped to generate over $10 billion of indirect and direct revenue.

For more information on the BioNJ Entrepreneurship Program, or to register for the event, please visit www.bionj.org.

About GENEWIZ
GENEWIZ is a global leader in R&D genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in DNA sequencing, gene synthesis, molecular biology, high-throughput sequencing, bioinformatics, and GLP regulatory-compliant services.

Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.  For more information, visit www.genewiz.com, and connect with us on LinkedIn, Twitter, Facebook, YouTube, and Weibo.

About the BIRD Foundation
The BIRD (Binational Industrial Research and Development) Foundation works to encourage and facilitate cooperation between U.S. and Israeli companies in a wide range of technology sectors and offers funding to selected projects. BIRD has approved over 900 projects over its 37 year history. To date, BIRD's total investment in these projects has been over $300 million and has received approximately $100 million in repayments. BIRD funded projects have generated direct and indirect sales of approximately $10 billion.

The BIRD Foundation provides support of up to 50% of a project's budget, or up to $1 million, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation supports projects without receiving any rights in the participating companies or in the project itself. The Foundation shares the risk and requires the investment to be repaid only if the project reaches the sales stage.

About Hy Laboratories Ltd.
Hy Laboratories Ltd (hylabs), is Israel's leading developer, manufacturer and distributor of tools for detection and identification of microorganisms and molecular biology products. hylabs provides a full range of products and services to the healthcare, industrial, environmental, and academic research markets.

SOURCE GENEWIZ



RELATED LINKS

http://www.genewiz.com
http://www.genewiz.com